BSECorp. ActionResults1d ago
Medicamen Biotech Ltd-$
Board of Directors has been approved the closure of Register of Members and Share Transfer Books from September 19, 2026 to September 25, 2026 in connection with the proposed payment of ....
Medicamen Biotech Ltd has announced the closure of its Register of Members and Share Transfer Books from September 19, 2026 to September 25, 2026, in connection with the proposed payment of a 10% final dividend. The company has also approved its unaudited financial results for the quarter ended June 30, 2026, and has scheduled its 33rd Annual General Meeting for September 26, 2026.
BSEResultResults1d ago
Medicamen Biotech Ltd-$
Financial Results for the quarter ended on June 30, 2026.
Medicamen Biotech Ltd announced its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the unaudited financial results (standalone and consolidated) for the quarter. The company also announced the closure of the register of members and share transfer books from September 19 to 25, 2026, in connection with the proposed payment of a final dividend. The Board took note of notices/communications received from stock exchanges regarding non-compliance/compliance-related matters.
BSEBoard MeetingResults7 Aug 2026
Medicamen Biotech Ltd-$
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Medicamen Biotech Ltd has scheduled a Board Meeting on August 14, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026, and other related matters.
BSECompany Update28 Jul 2026
Medicamen Biotech Ltd-$
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Medicamen Biotech Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended June 30, 2026, detailing securities dematerialized and rematerialized during the period.